ACH (Accendra Health) Total Stockholders Equity: $-465 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACH Accendra Health Inc ACH
59 GF Score
Price $3.41
GF Value $5.44
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Accendra Health Total Stockholders Equity?

Accendra Health ACH +10.36% 59 Total Stockholders Equity is $-465 Mil as of Mar. 2026. GuruFocus rates ACH with a GF Score™ of 59/100 and a GF Value™ of $5.44 (Possible Value Trap). The stock has 7 warning signs investors should review.

Accendra Health's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $-465 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Accendra Health's Book Value per Share for the quarter that ended in Mar. 2026 was $-6.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Accendra Health's Debt-to-Equity for the quarter that ended in Mar. 2026 was -4.67.

Accendra Health  (NYSE:ACH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Accendra Health's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-464.765-0)/76.584
=-6.07

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Accendra Health's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(581.25 + 1589.407) / -464.765
=-4.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Total Stockholders Equity Related Terms

Accendra Health Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Accendra Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Total Stockholders Equity Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 938.50 945.60 924.17 586.36 -460.98

Accendra Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 570.98 -281.01 -429.51 -460.98 -464.77
ACH
59GF Score
Accendra Health Inc ACH
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $-465 Mil mean?
Accendra Health (ACH) has a Total Stockholders Equity of $-465 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Accendra Health and its competitors.
Is Accendra Health's Total Stockholders Equity too high?
Accendra Health's current Total Stockholders Equity is $-465 Mil. Overall, Accendra Health has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Total Stockholders Equity compare to FOCL and YI?
Accendra Health's Total Stockholders Equity of $-465 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Distribution company?
A good Total Stockholders Equity depends on the Medical Distribution industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Accendra Health and its competitors. Accendra Health's current Total Stockholders Equity is $-465 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.44, compared to a current price of $3.41 — trading 37.3% below its estimated fair value. The current Total Stockholders Equity is $-465 Mil. Accendra Health's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Accendra Health (ACH), the current Total Stockholders Equity is $-465 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.41 is trading 37.3% below its estimated GF Value™ of $5.44. GuruFocus considers Accendra Health to be Possible Value Trap.

Key valuation signals for ACH:

  • Total Stockholders Equity: $-465 Mil
  • GF Value™: $5.44 vs. price of $3.41 (37.3% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
59GF Score

Get the complete analysis for ACH

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.41
Price
$5.44
GF Value